EU IVD Regulation Delaying Clinical Trials Using Diagnostics
Lack Of Coordination On Performance Study Applications Negatively Affecting Drug Trials
Executive Summary
The challenges posed by the implementation of the EU IVD Regulation are having a negative impact on medicine trials using diagnostics. Many such studies are currently stalled and research-based drug companies are calling on all partners to engage in dialog to find an urgent solution.